Company Tagline
Personalized T-cell therapies for hematologic malignancies and solid tumors.
Industry Category
Business Keywords
Company Description
BlueSphere Bio is a pioneering biotechnology research company focused on unlocking the potential of personalized T-cell therapy for cancer treatment. Leveraging the innovative TCXpress technology, BlueSphere Bio harnesses the unique specificity of each patient’s T-cells to target the molecular fingerprint of their cancer, offering a personalized approach to treatment.
Located at 350 Technology Drive, Suite 520, Pittsburgh, PA 15219, US, BlueSphere Bio is dedicated to developing rapid and personalized T-cell treatments for various cancer indications. The proprietary TCXpress platform is designed to exploit the patient's immune defenses to attack cancer specifically while leaving normal tissues untouched, thereby reducing harmful side effects. BlueSphere Bio's commitment to innovation drives its mission to advance cancer treatment through cutting-edge biotechnological solutions.
BlueSphere Bio is committed to advancing the field of immunotherapy and oncology through personalized T-cell therapies. The company is poised for continued growth and development in the biotechnology sector. We invite the management team at BlueSphere Bio to enhance your company's visibility by creating a customized and exclusive company showcase and product listing on our platform, which will be completed soon with the support of the company’s management.
BlueSphere Bio est une entreprise pionnière de recherche en biotechnologie axée sur la libération du potentiel de la thérapie personnalisée des lymphocytes T pour le traitement du cancer. En exploitant la technologie innovante TCXpress, BlueSphere Bio exploite la spécificité unique des lymphocytes T de chaque patient pour cibler l'empreinte moléculaire de son cancer, offrant ainsi une approche personnalisée du traitement.
Située au 350 Technology Drive, Suite 520, Pittsburgh, PA 15219, États-Unis, BlueSphere Bio se consacre au développement de traitements rapides et personnalisés des lymphocytes T pour diverses indications de cancer. La plateforme exclusive TCXpress est conçue pour exploiter les défenses immunitaires du patient afin d'attaquer spécifiquement le cancer tout en laissant les tissus normaux intacts, réduisant ainsi les effets secondaires nocifs. L'engagement de BlueSphere Bio envers l'innovation stimule sa mission de faire progresser le traitement du cancer grâce à des solutions biotechnologiques de pointe.
BlueSphere Bio s'engage à faire progresser le domaine de l'immunothérapie et de l'oncologie grâce à des thérapies personnalisées des lymphocytes T. L'entreprise est sur le point de connaître une croissance et un développement continus dans le secteur de la biotechnologie. Nous invitons l'équipe de direction de BlueSphere Bio à améliorer la visibilité de votre entreprise en créant une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme, qui sera bientôt complétée avec le soutien de la direction de l'entreprise.
Key Personnel / Employees
Compare Companies Side by Side
Compare BlueSphere Bio with 3 companies in Biotechnology-Research
| Comparison Field |
BlueSphere BioMain Company |
medac GmbHView Profile |
Healthcare Education...View Profile |
VIOLET Pharmaceutica...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 1970 | 1977 | |
|
Company Size
|
— | 1,001-5,000 | 1 employee | 2-10 |
|
City
|
Pittsburgh, PA | Wedel (Holstein), SH | St Albans, Herts | |
|
Country
|
United States | United Kingdom | ||
|
Skills & Keywords
Comparing with main company
|
11 Total Skills
T-cell therapy
Immunotherapy
Oncology
Biotechnology
Cancer treatment
Personalized medicine
TCXpress platform
T-cell therapies
Immunotherapies
Autoimmune diseases
T-cell treatments
|
5 Total
5 Unique
Unique Skills:
Dermatology
Diagnostics
Haematology
Rheumatology
Urology
|
10 Total
10 Unique
Unique Skills:
Biotech Industry
Breast Cancer
Haematological Malignancies
Health Economics
Hospital based learning
Medical Device Industry
+4
|
18 Total
1 Common
17 Unique
Match
9%
Common Skills:
Immunotherapy
Unique Skills:
Adoptive Cell Transfer
Antigen Presentation Machinery
Biopharma
Deeptech
Drug Development
gene therapy
+11
|
4
Total Companies1970
Oldest Founded2
Countries43
Unique SkillsSimilar Companies
Other organizations in the same industry
Zena Therapeutics Inc.
Biotechnology-ResearchAn innovative drug discovery company focused on patient safety.
KYAN Technologies
Biotechnology-ResearchKYAN is a biotechnology company redefining how therapies are offered to patients.
Panosome GmbH
Biotechnology-ResearchTargeting the untargetable
Monument Therapeutics
Biotechnology-ResearchBringing Precision Medicine to Neuroscience Drug Development
Alternative Company Names
This company is also known as